最美情侣中文字幕电影,在线麻豆精品传媒,在线网站高清黄,久久黄色视频

歡迎光臨散文網(wǎng) 會員登陸 & 注冊

【熱門產(chǎn)品推薦】派安普利單抗,Penpulimab, AntibodySystem Laboratories

2023-06-15 10:44 作者:AtaGenix-普健生物  | 我要投稿

派安普利單抗,Penpulimab,CAS: 2350298-92-7,AntibodySystem Laboratories

貨號:DHH02225

產(chǎn)品鏈接:http://www.atagenix.com/product_detail-74831.html

別名:AK-105, CAS: 2350298-92-7

簡介:

派安普利單抗 Penpulimab 是一種 IgG1 抗 PD-1 單克隆抗體,具有抗腫瘤活性。

貨號:DHH02225

產(chǎn)品品牌:Antibodysystem

通用名:Penpulimab

純度:>95% by SDS-PAGE.

濃度:1mg/ml

Formulationicon:0.01M PBS, pH 7.4.

內(nèi)毒素:Please contact with the lab for this information.

別名:AK-105

靶點;物種:Human CD279/PDCD1/PD1

種類:Humanized

受體鑒定:IgG1-Kappa

CAS: 2350298-92-7

存儲條件:

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

Store at +4°C short term (1-2 weeks).

Store at -20 °C 12 months.

Store at -80°C long term.

參考文獻(xiàn):

Penpulimab: First Approval. PMID: 34813051

Antibodies to watch in 2022. PMID: 35030985

Penpulimab, an anti-PD1 IgG1 antibody in the treatment of advanced or metastatic upper gastrointestinal cancers. PMID: 35165764

Penpulimab, an Fc-Engineered IgG1 Anti-PD-1 Antibody, With Improved Efficacy and Low Incidence of Immune-Related Adverse Events. PMID: 35833116

Clinical Activity and Safety of Penpulimab (Anti-PD-1) With Anlotinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: An Open-Label, Multicenter, Phase Ib/II Trial (AK105-203). PMID: 34327136

Penpulimab for Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter, Single-Arm, Pivotal Phase I/II Trial (AK105-201). PMID: 35875118

Corrigendum: Successful treatment of a patient with multiple-line relapsed extensive-stage small-cell lung cancer receiving penpulimab combined with anlotinib: A case report. PMID: 36033531

Autoimmune hemolytic anemia in patients with relapsed Hodgkin's lymphoma after treatment with penpulimab, a monoclonal antibody against programmed death receptor-1. PMID: 35503192

Successful Treatment of a Patient With Multiple-Line Relapsed Extensive-Stage Small-Cell Lung Cancer Receiving Penpulimab Combined With Anlotinib: A Case Report. PMID: 35321433


【熱門產(chǎn)品推薦】派安普利單抗,Penpulimab, AntibodySystem Laboratories的評論 (共 條)

分享到微博請遵守國家法律
娄底市| 乌拉特后旗| 云安县| 汉沽区| 远安县| 古丈县| 松原市| 洞头县| 临夏县| 贡觉县| 永州市| 宁城县| 通山县| 泰来县| 岗巴县| 分宜县| 维西| 揭东县| 金门县| 砚山县| 时尚| 嘉鱼县| 文化| 济源市| 绥芬河市| 本溪| 兴文县| 延津县| 台前县| 乌拉特后旗| 醴陵市| 萝北县| 凤阳县| 平陆县| 鄂温| 丹凤县| 安溪县| 昆山市| 元谋县| 梅河口市| 尼木县|